Company Announcements

Edison issues review on Templeton Emerging Markets

Source: RNS
RNS Number : 4905Y
Templeton Emerging Markets IT PLC
14 January 2022
 

 

London, UK, 14 January 2022

 

Edison issues review on Templeton Emerging Markets Investment Trust (TEM)

Templeton Emerging Markets Investment Trust (TEMIT) is by far the largest fund in the AIC Global Emerging Markets sector. Its two managers Chetan Sehgal (lead manager) and Andrew Ness seek companies with robust business models, sustainable earnings growth potential and which are trading at a discount to their estimated intrinsic values. The managers' considerable experience, coupled with the deep resources of a broad investment team, enables them to identify interesting opportunities that may be overlooked by other investors. While TEMIT's performance has been disappointing over the last 12 months, partly due to a tighter Chinese regulatory environment, the trust has outpaced the performance of the MSCI Emerging Markets Index over the last three and five years.

In July 2021 there was a 5:1 share split with the objective of facilitating smaller investments and the reinvestment of dividends. TEMIT is currently trading at a 9.4% discount to cum-income NAV, which is within the range of 8.9% to 11.2% average discounts over the last one, three, five and 10 years. Dividends are paid semi-annually in January and July and the trust's current yield is 2.1%. TEMIT is subject to a five-year continuation vote; the next is due in July 2024.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Victoria Chernykh +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn        https://www.linkedin.com/company/edison-group-/

Twitter             www.twitter.com/Edison_Inv_Res 

YouTube       www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANFLFDFAEEA